Scarica l'app Stockscreener
17.84
2.86%
0.535
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BAX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$17.31
Aprire:
$17.57
Volume 24 ore:
1.92M
Relative Volume:
0.21
Capitalizzazione di mercato:
$9.21B
Reddito:
$11.32B
Utile/perdita netta:
$-981.00M
Rapporto P/E:
-9.1363
EPS:
-1.9532
Flusso di cassa netto:
$714.00M
1 W Prestazione:
+1.80%
1M Prestazione:
+1.22%
6M Prestazione:
-3.60%
1 anno Prestazione:
-41.28%
Intervallo 1D:
$17.39
$17.98
Intervallo di 1 settimana:
$17.09
$18.09
Portata 52W:
$15.73
$32.04
Baxter International Inc Stock (BAX) Company Profile
Nome
Baxter International Inc
Settore
Industria
Telefono
(224) 948-2000
Indirizzo
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, MDLN, ALC, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
17.84 | 8.94B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
428.56 | 153.09B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.75 | 39.73B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
38.88 | 32.73B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
64.08 | 30.94B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
202.82 | 29.36B | 5.54B | 1.52B | 1.74B | 10.37 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-31 | Downgrade | Argus | Buy → Hold |
| 2025-08-04 | Downgrade | Stifel | Buy → Hold |
| 2025-08-01 | Downgrade | Goldman | Buy → Neutral |
| 2025-02-26 | Ripresa | Goldman | Buy |
| 2025-02-24 | Aggiornamento | Argus | Hold → Buy |
| 2025-02-20 | Ripresa | Barclays | Overweight |
| 2024-07-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-10 | Downgrade | TD Cowen | Buy → Hold |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-12-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-06-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Goldman | Neutral → Sell |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-18 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Reiterato | Morgan Stanley | Overweight |
| 2022-02-18 | Reiterato | Raymond James | Outperform |
| 2022-02-18 | Reiterato | Stifel | Buy |
| 2022-02-18 | Reiterato | UBS | Neutral |
| 2022-02-18 | Reiterato | Wells Fargo | Overweight |
| 2022-02-11 | Iniziato | Goldman | Neutral |
| 2022-01-07 | Ripresa | Citigroup | Buy |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-09-03 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Downgrade | UBS | Buy → Neutral |
| 2020-12-15 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-09-04 | Downgrade | Argus | Buy → Hold |
| 2020-06-24 | Iniziato | Oppenheimer | Outperform |
| 2020-03-19 | Aggiornamento | Stifel | Hold → Buy |
| 2020-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-01-02 | Aggiornamento | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-10-16 | Iniziato | Barclays | Underweight |
| 2018-05-17 | Ripresa | Piper Jaffray | Overweight |
| 2018-02-06 | Reiterato | Citigroup | Neutral |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2018-01-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
Mostra tutto
Baxter International Inc Borsa (BAX) Ultime notizie
First Pacific Advisors' Strategic Moves: Baxter International Inc. Takes Center Stage - GuruFocus
Baxter International Inc (BAX) Stock Down 3.2% -- Now Undervalued? GF Score: 66/100 - GuruFocus
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Baxter International stock (US0673431090): Gains 2.05% to $17.89 - AD HOC NEWS
Transcript : Baxter International Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 11 - marketscreener.com
Baxter International Inc. stock (US0673431090): Recent 2% price gain on NYSE - AD HOC NEWS
Baxter International Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Baxter International Inc stock (US0718131099): Shares drop 2.56% to $17.53 - AD HOC NEWS
Baxter International stock outlook: Is Wall Street bullish or bearish? - MSN
Baxter International earnings preview: What to expect - MSN
Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Rare Hemophilia Factors Market Is Going to Boom |• Baxter International • Novo Nordisk • Pfizer - openPR.com
Baxter International Inc. stock (US0673431090): Q1 2026 earnings beat consensus - AD HOC NEWS
Precision Trading with Baxter International Inc. (BAX) Risk Zones - Stock Traders Daily
Baxter International shareholders approve board slate, pay and incentive plan at annual meeting - MSN
Baxter International Shareholders Approve Board Slate, Pay and Incentive Plan at Annual Meeting - Barchart.com
Baxter International Inc. stock (US0673431090): Governance shake?up and earnings pressure in focus - AD HOC NEWS
Baxter Updates Executive Severance Plan and Governance Framework - TipRanks
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter International updates executive severance plan and amends bylaws after annual meeting - Investing.com
Baxter (NYSE: BAX) expands severance protections and adds 20M incentive shares - Stock Titan
Infusion Therapy Market Is Going to Boom | Baxter International, B. Braun Melsungen AG, Fresenius Kabi AG - openPR.com
BAX Stock Price, Quote & Chart | BAXTER INTERNATIONAL INC (NYSE:BAX) - ChartMill
Baxter International Still Has A Path To Upside - Seeking Alpha
Director at Baxter (NYSE: BAX) receives 12,836 fully vested share award, now holds 37,076 - Stock Titan
Baxter (BAX) director Amy McBride receives 12,836-share fully vested stock grant - Stock Titan
Director at Baxter (NYSE: BAX) awarded 12,836 shares, holds 34,994 - Stock Titan
Baxter International (BAX) director awarded 12,836 fully vested shares - Stock Titan
Baxter (BAX) board chair David Brent Shafer receives 12,836-share stock grant - Stock Titan
Director Michael McDonnell of Baxter (NYSE: BAX) receives 12,836-share fully vested grant - Stock Titan
Director Jeffrey A. Craig receives 12,836 Baxter (BAX) shares in grant - Stock Titan
Baxter (NYSE: BAX) director awarded 12,836 fully vested shares in Form 4 - Stock Titan
MSN Money - MSN
Becton Dickinson at 13x Earnings: MedTech’s Most Mispriced Compounder - Investing.com
Baxter International Inc. stock rises Wednesday, still underperforms market - MarketWatch
FMR LLC reports 9.0% stake in Baxter International (BAX) — 46.3M shares - Stock Titan
Assessing Baxter International’s Valuation After Earnings Beat And Guidance Reaffirmation - simplywall.st
Pheochromocytoma Market to Reach USD 3.86 Billion by 2033 at 8.5% - openPR.com
Franklin Mutual U.S. Mid Cap Value Fund's Baxter International Inc(BAX) Holding History - GuruFocus
The Adirondack Small Cap Fund's Baxter International Inc(BAX) Holding History - GuruFocus
Baxter International Stock Outlook: Is Wall Street Bullish or Bearish? - Barchart.com
Barclays Maintains Baxter International Inc(BAX.US) With Buy Rating, Maintains Target Price $27 - Moomoo
Baxter International Inc. (BAX) Stock Analysis: Exploring a 28.5% Potential Upside for Healthcare Investors - DirectorsTalk Interviews
Research Alert: CFRA Keeps Hold Rating On Shares Of Baxter International Inc. - 富途牛牛
Baxter International 1Q Loss $15M >BAX - Moomoo
Assessing Baxter International (BAX) Valuation After Earnings Beat And Reaffirmed Outlook - Yahoo Finance
Baxter International Inc. (NYSE:BAX) Given Consensus Rating of "Reduce" by Brokerages - MarketBeat
Baxter International (BAX) Is Down 5.2% After Q1 Loss But Turnaround Guidance ReaffirmedWhat's Changed - Yahoo Finance
Baxter Profit Plunges 35% As Tariffs, Costs Bite - Sahm
Baxter International (NYSE:BAX) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says - MarketBeat
Baxter International (NYSE:BAX) Given New $19.00 Price Target at Stifel Nicolaus - MarketBeat
Baxter International Inc Azioni (BAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.57%
0.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):